Frederic Gervais

ESTP Congress
,

Director of Pathology, Charles River Laboratories, Évreux, France
Dr. Frédéric Gervais is Director of Pathology at Charles River Laboratories in Évreux, France. He leads multidisciplinary teams in histology, molecular pathology, and toxicologic pathology, supporting preclinical drug development programs for global pharmaceutical and biotechnology clients.
His expertise focuses on toxicologic pathology, immunopathology, and translational science, with particular emphasis on large molecules and immuno-oncology. He has extensive experience in advanced tissue-based technologies, including immunohistochemistry, in situ hybridization, and multiplex spatial biology approaches.

Dr. Gervais is actively involved in the integration of digital pathology and artificial intelligence into preclinical workflows, including the development and qualification of image analysis applications in a regulatory context.